Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Eiji Fukuhara"'
Autor:
Hideyuki Kishima, Takanao Mine, Eiji Fukuhara, Ryo Kitagaki, Masanori Asakura, Masaharu Ishihara
Publikováno v:
JACC: Clinical Electrophysiology. 8:1393-1404
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have recently been a significant focus of attention because of their multiple pleiotropic effects. However, the impact of SGLT2i on atrial fibrillation (AF) remains unclear.The goal of this study was
Publikováno v:
Journal of Cardiology. 77:195-200
Cardiac implantable electronic device-detected atrial high-rate episodes (AHREs) have been reported to be associated with thromboembolic risks. The present study aimed to investigate the association of echocardiographic and clinical parameters with t
Publikováno v:
Heart and Vessels. 35:1227-1233
Left atrial appendage thrombi (LAAT) are the main cause of thromboembolic events. Especially, movable type LAAT is high-risk for thromboembolic events. We aimed to investigate the predictors of the movable type LAAT in patients with atrial fibrillati
Publikováno v:
Journal of the American College of Cardiology. 81:80
Publikováno v:
Journal of the American College of Cardiology. 81:93
Autor:
Takanao Mine, Hideyuki Kishima, Eiji Fukuhara, Ryo Kitagaki, Takehiro Kogame, Masaharu Ishihara
Publikováno v:
Journal of the American College of Cardiology. 81:84
Publikováno v:
Journal of the American College of Cardiology. 81:139
Autor:
Hideyuki Kishima, Takanao Mine, Eiji Fukuhara, Ryo Kitagaki, Masanori Asakura, Masaharu Ishihara
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
European Heart Journal. 42
Background Left atrial appendage thrombi (LAAT), especially movable type LAAT, have been reported to be high-risk for thromboembolic events in patients with atrial fibrillation (AF). However, thromboembolic risk of the movable-type LAAT under widespr
Publikováno v:
European Heart Journal. 42
Background The abnormal conduction zone (ACZ) in the left atrium (LA) has attracted attention as an arrhythmia substrate in atrial fibrillation (AF). Purpose We investigated whether the ACZ affects outcomes after catheter ablation (CA) for AF. Method